GLP-1, an endogenous polypeptide hormone released in response to food intake, potentiate insulin secretion from pancreatic cells through binding and activation of its receptor, and GLP-1R agonists have emerged as treatment options for type 2 diabetes mellitus. The gene discussed is GCG; the disease is type 2 diabetes mellitus.